NATRNasdaq

NATURES SUNSHINE PRODUCTS INC

Consumer Defensive·Consumer Defensive·Lehi, UT, United States
Healthy/Normal

NATURES SUNSHINE PRODUCTS INC (NATR): 2 pipeline candidates · ~187 mo cash runway · 1 clinical trial. Updated within the last hour.

6.4/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway10.0

186.7 months

Financial Health9.6

2% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth4.6

2 candidates

Catalyst MomentumN/A

N/A

Insider Signal1.5

0 buys · 5 sells (180d)

A transparent, data-derived signal for NATURES SUNSHINE PRODUCTS INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$360.7M

Cash

$87.6M

Quarterly Burn

$1.8M

Runway

186.7 mo

Revenue

$122.9M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Jan 2042
Today~205 mo out
Catalyst within runway

Pipeline (2 candidates)

DrugPhase
beactive brace
beactive brace

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

150

Total value held

$262.4M

HolderSharesValue
vanguard capital management llc1,193,666$28.6M
blackrock, inc.1,064,454$25.5M
dimensional fund advisors lp895,437$21.5M
kennedy capital management llc691,498$16.6M
american century companies inc574,825$13.8M
renaissance technologies llc531,924$12.8M
geode capital management, llc372,549$8.9M
punch & associates investment management, inc.340,000$8.2M
state street corp325,805$7.8M
hillsdale investment management inc.316,867$7.6M

Showing top 10 of 150 institutional holders of NATURES SUNSHINE PRODUCTS INC. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

1 clinical trial·CEO: Mr. Kenneth G. Romanzi

Frequently asked questions

How many drug candidates are in NATURES SUNSHINE PRODUCTS INC's pipeline?

NATURES SUNSHINE PRODUCTS INC (NATR) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is NATURES SUNSHINE PRODUCTS INC's cash runway?

Based on its most recent reported cash balance and quarterly burn rate, NATURES SUNSHINE PRODUCTS INC has approximately 186.7 months of cash runway.

What is NATURES SUNSHINE PRODUCTS INC's market capitalization?

NATURES SUNSHINE PRODUCTS INC's market capitalization is approximately $360.7M.

Who is the CEO of NATURES SUNSHINE PRODUCTS INC?

Mr. Kenneth G. Romanzi is the chief executive officer of NATURES SUNSHINE PRODUCTS INC (NATR).

Get the full picture on NATURES SUNSHINE PRODUCTS INC

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.